Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 Görünümler
administrator
07/10/23
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Daha fazla göster
Facebook Yorumları
Hiçbir yorum bulunamadı